Document Detail


Five years of anti-resorptive activity after a single dose of zoledronate - Results from a randomized double-blind placebo-controlled trial.
MedLine Citation:
PMID:  22465268     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Intravenous zoledronate 5mg, administered annually, prevents fractures in people with osteoporosis, but the optimal dosing schedule is not known. Previously, we reported that a single dose of 5mg zoledronate stably decreased bone turnover and increased bone mineral density (BMD) for 3years in a randomized controlled trial in 50 postmenopausal women with osteopenia. We have now completed a 2-year double-blind extension of this trial, during which no additional treatment was administered. The primary endpoint was change in the bone turnover marker procollagen type-I N-terminal propeptide (P1NP) and β-C-terminal telopeptide of type I collagen (β-CTX); the secondary endpoint was change in BMD at lumbar spine, total hip and total body. Mean levels of the each of the bone turnover markers were lower in the zoledronate group throughout the study (P<0.0001 for each marker). After 5years, mean (95% CI) levels of β-CTX and P1NP were 277ng/L (150, 404) and 28μg/L (16, 40) lower in the zoledronate group, corresponding to reductions of 48% and 45%, respectively. BMD was higher in the zoledronate group during the study (P<0.0001 for each site). After 5years, BMD in the zoledronate group was higher by 4.2% (1.1, 7.2) at the lumbar spine, by 5.3% (2.7, 7.9) at the total hip, and by 2.7% (1.1, 4.2) at the total body. These findings suggest that the anti-resorptive effects of a single 5mg dose of zoledronate persist for at least 5years in postmenopausal women. Trials assessing the anti-fracture efficacy of dosing intervals of zoledronate of up to 5years are justified.
Authors:
Andrew Grey; Mark J Bolland; Anne Horne; Diana Wattie; Meaghan House; Greg Gamble; Ian R Reid
Related Documents :
22640438 - Placental size at 19 weeks predicts offspring bone mass at birth: findings from the sou...
22276078 - Conservative approach to unilateral condylar fracture in a growing patient: a 2.5-year ...
12750848 - The incorporation of different sorts of cancellous bone graft and the reaction of the h...
22762248 - Traumatic extradural haematoma revealed after contralateral decompressive craniectomy.
16951098 - Femoral component revision with use of impaction bone-grafting and a cemented polished ...
15941168 - An unusual radiographic presentation of posterior cruciate ligament avulsion fracture.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-3-24
Journal Detail:
Title:  Bone     Volume:  -     ISSN:  1873-2763     ISO Abbreviation:  -     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-4-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8504048     Medline TA:  Bone     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012. Published by Elsevier Inc.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Associations between dietary cadmium exposure and bone mineral density and risk of osteoporosis and ...
Next Document:  Serum myeloperoxidase activity and oxidative stress in patients with acute brucellosis.